Western blotting (Fig 6H) and immunohistochemical staining (Fig 6I) confirmed that GPX4 expression was downregulated in the tumor lesions formed by NeuroD1-knocked down HCC-LM3 cells. Here, GPX4 is linked to hepatocellular carcinoma.